Laurion Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104M | Sell |
2,411,248
-566,919
| -19% | -$24.5M | 1.88% | 3 |
|
|
2025
Q1 | $103M | Sell |
2,978,167
-762,729
| -20% | -$26.4M | 2.59% | 4 |
|
|
2024
Q4 | $103M | Sell |
3,740,896
-153,386
| -4% | -$4.21M | 1.88% | 5 |
|
|
2024
Q3 | $99.1M | Sell |
3,894,282
-494,591
| -11% | -$12.6M | 1.35% | 5 |
|
|
2024
Q2 | $111M | Sell |
4,388,873
-787,455
| -15% | -$19.9M | 1.32% | 8 |
|
|
2024
Q1 | $160M | Sell |
5,176,328
-65,505
| -1% | -$2.03M | 1.36% | 1 |
|
|
2023
Q4 | $212M | Sell |
5,241,833
-409,206
| -7% | -$16.5M | 1.79% | 2 |
|
|
2023
Q3 | $149M | Buy |
5,651,039
+901,696
| +19% | +$23.8M | 0.91% | 7 |
|
|
2023
Q2 | $81.7M | Buy |
4,749,343
+1,236,584
| +35% | +$21.3M | 0.46% | 5 |
|
|
2023
Q1 | $58.2M | Buy |
3,512,759
+1,289,505
| +58% | +$21.4M | 0.4% | 8 |
|
|
2022
Q4 | $16.9M | Buy |
2,223,254
+198,614
| +10% | +$1.51M | 0.08% | 39 |
|
|
2022
Q3 | $20.1M | Buy |
2,024,640
+550,190
| +37% | +$5.47M | 0.12% | 40 |
|
|
2022
Q2 | $13.4M | Buy |
1,474,450
+778,535
| +112% | +$7.07M | 0.21% | 32 |
|
|
2022
Q1 | $7.06M | Buy |
+695,915
| New | +$7.06M | 0.09% | 57 |
|
|
2019
Q4 | – | Sell |
-11,200
| Closed | -$240K | – | 509 |
|
|
2019
Q3 | $240K | Sell |
11,200
-13,800
| -55% | -$296K | ﹤0.01% | 506 |
|
|
2019
Q2 | $674K | Buy |
+25,000
| New | +$674K | 0.01% | 337 |
|